2 results match your criteria: "Department of Internal Medicine II-Division of Cardiology Medical University of Vienna Vienna Austria.[Affiliation]"
Association of Periprocedural Inflammatory Activation With Increased Risk for Early Coronary Stent Thrombosis.
J Am Heart Assoc
January 2024
Article Synopsis
- Stent thrombosis is a rare but serious complication that can occur after percutaneous coronary intervention (PCI), especially when patients show signs of acute inflammation.
- In a study of 6880 patients undergoing PCI, those with elevated inflammatory markers had a nearly threefold increased risk of experiencing early stent thrombosis within 30 days.
- The findings suggest that if there are indicators of acute inflammation, elective PCI should be postponed, and further research is necessary for those with acute coronary syndrome.
Plasma Neprilysin Displays No Relevant Association With Neurohumoral Activation in Chronic HFrEF.
J Am Heart Assoc
June 2020
Background Neprilysin is a transmembrane endopeptidase involved in the breakdown of a variety of vasoactive peptides and serves as a therapeutic target in heart failure with reduced ejection fraction (HFrEF). This study aimed to investigate the relationship of circulating neprilysin with neurohumoral activation and the impact of plasma neprilysin activity on prognosis in HFrEF. Methods and Results A total of 369 chronic HFrEF patients were enrolled prospectively.
View Article and Find Full Text PDF